206 related articles for article (PubMed ID: 35217937)
41. Foam sclerotherapy with Fibrovein (STD) for the treatment of hemorrhoids, using a flexible endoscope.
Benin P; D'Amico C
Minerva Chir; 2007 Aug; 62(4):235-40. PubMed ID: 17641583
[TBL] [Abstract][Full Text] [Related]
42. Polidocanol for endovenous microfoam sclerosant therapy.
Eckmann DM
Expert Opin Investig Drugs; 2009 Dec; 18(12):1919-27. PubMed ID: 19912070
[TBL] [Abstract][Full Text] [Related]
43. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
44. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
[TBL] [Abstract][Full Text] [Related]
45. Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices.
Al Traif I; Fachartz FS; Al Jumah A; Al Johani M; al-Omair A; al-Bakr F; al-Knawy B; el-Hafi A; Khan MH
Gastrointest Endosc; 1999 Jul; 50(1):1-6. PubMed ID: 10385713
[TBL] [Abstract][Full Text] [Related]
46. Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as "bridge treatment" during the COVID-19 pandemic in Italy.
Lisi G; Campanelli M; Grande S; Milito G; Grande M
Int J Colorectal Dis; 2021 Jun; 36(6):1321-1322. PubMed ID: 33452908
[TBL] [Abstract][Full Text] [Related]
47. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients.
Chung SH; Lee MS; Kim KS; Kim SI; Won JY; Lee DY; Lee KH
Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1236-43. PubMed ID: 21290126
[TBL] [Abstract][Full Text] [Related]
48. Use of video-guided sclerotherapy with 3% polidocanol foam for symptomatic second-degree haemorrhoidal disease - a video vignette.
Skowronski A; Diaco E; Trompetto M; Gallo G
Colorectal Dis; 2020 Sep; 22(9):1198-1199. PubMed ID: 32180308
[No Abstract] [Full Text] [Related]
49. Endoscopic hemorrhoidal sclerotherapy using 50% dextrose water: a preliminary report.
Alatise OI; Arigbabu OA; Lawal OO; Adesunkanmi AK; Agbakwuru AE; Ndububa DA; Akinola DO
Indian J Gastroenterol; 2009; 28(1):31-2. PubMed ID: 19529900
[TBL] [Abstract][Full Text] [Related]
50. A prospective randomised comparative study of endoscopic band ligation versus injection sclerotherapy of bleeding internal haemorrhoids in patients with liver cirrhosis.
Awad AE; Soliman HH; Saif SA; Darwish AM; Mosaad S; Elfert AA
Arab J Gastroenterol; 2012 Jun; 13(2):77-81. PubMed ID: 22980596
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
[TBL] [Abstract][Full Text] [Related]
52. Emergency sclerotherapy for esophageal variceal bleeding.
Paterlini A; Lanzani G; Graffeo M; Buffoli F; Cesari P; Benedini D; Pascarella A; Rolfi F
Gastrointest Endosc; 1992; 38(6):732-3. PubMed ID: 1473690
[No Abstract] [Full Text] [Related]
53. Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations.
Kitagawa A; Yamamoto T; Matsunaga N; Yamaji M; Ikeda S; Izumi Y; Hagihara M; Ota T; Ishiguchi T
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):856-866. PubMed ID: 29417264
[TBL] [Abstract][Full Text] [Related]
54. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up.
Blaise S; Bosson JL; Diamand JM
Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):779-86. PubMed ID: 20206556
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
Ali H; Saleh M; Mohammed W
Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
[TBL] [Abstract][Full Text] [Related]
56. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
Todd KL; Wright DI;
Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
[TBL] [Abstract][Full Text] [Related]
57. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
Bertanha M; Jaldin RG; Moura R; Pimenta REF; Mariúba JVO; Lúcio Filho CEP; Alcantara GP; Padovani CR; Yoshida WB; Sobreira ML
JAMA Dermatol; 2017 Dec; 153(12):1249-1255. PubMed ID: 28973414
[TBL] [Abstract][Full Text] [Related]
58. A prospective randomized study comparing polidocanol foam sclerotherapy with surgical treatment of patients with primary chronic venous insufficiency and ulcer.
Campos W; Torres IO; da Silva ES; Casella IB; Puech-Leão P
Ann Vasc Surg; 2015 Aug; 29(6):1128-35. PubMed ID: 26004968
[TBL] [Abstract][Full Text] [Related]
59. Conservative management of hemorrhoids: a comparison of venotonic flavonoid micronized purified flavonoid fraction (MPFF) and sclerotherapy.
Yuksel BC; Armagan H; Berkem H; Yildiz Y; Ozel H; Hengirmen S
Surg Today; 2008; 38(2):123-9. PubMed ID: 18239868
[TBL] [Abstract][Full Text] [Related]
60. Percutaneous treatment of symptomatic non-parasitic hepatic cysts. Initial experience with single-session sclerotherapy with polidocanol.
Spârchez Z; Radu P; Zaharie F; Al Hajjar N; Sparchez M
Med Ultrason; 2014 Sep; 16(3):222-8. PubMed ID: 25110763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
